High Control Human Serum |
35-S4323H000-L4 |
Fitzgerald |
10 ml |
EUR 139.2 |
Description: High control human Serum |
Ige Serum Laboratories manufactures the serum ige high immunotherapy reagents distributed by Genprice. The Serum Ige High Immunotherapy reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact IgE Serum. Other Serum products are available in stock. Specificity: Serum Category: Ige Group: High Immunotherapy
High affinity IgE receptor subunit gamma Antibody (FITC) |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
High affinity IgE receptor subunit gamma Antibody (Biotin) |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
High affinity IgE receptor subunit gamma Antibody (HRP) |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Pig High affinity IgE Receptor Antibody ELISA kit |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Porcine High affinity IgE Receptor Antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig High affinity IgE Receptor Antibody ELISA kit |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Porcine High affinity IgE Receptor Antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig High affinity IgE Receptor Antibody ELISA kit |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Porcine High affinity IgE Receptor Antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
High Immunotherapy information
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)(PDL1/2745), 1mg/mL |
BNUM2745-50 |
Biotium |
1uL |
EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Monoclonal MAGE-1 (Target for Cancer Immunotherapy) Antibody, Clone: MA454 |
AMM00999G |
Leading Biology |
7 ml |
EUR 580.8 |
Description: A Monoclonal antibody against Human MAGE-1 (Target for Cancer Immunotherapy). The antibodies are raised in Mouse and are from clone MA454. This antibody is applicable in IHC, IF, FC |
Monoclonal MAGE-1 (Target for Cancer Immunotherapy) Antibody, Clone: SPM282 |
AMM01000G |
Leading Biology |
7 ml |
EUR 580.8 |
Description: A Monoclonal antibody against Human MAGE-1 (Target for Cancer Immunotherapy). The antibodies are raised in Mouse and are from clone SPM282. This antibody is applicable in IHC, IF, FC |
Monoclonal MAGE-1 (Target for Cancer Immunotherapy) Antibody, Clone: MZ2E/838 |
AMM01001G |
Leading Biology |
7 ml |
EUR 580.8 |
Description: A Monoclonal antibody against Human MAGE-1 (Target for Cancer Immunotherapy). The antibodies are raised in Mouse and are from clone MZ2E/838. This antibody is applicable in IHC, IF, FC |
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
BNC942746-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF594 conjugate, Concentration: 0.1mg/mL |
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
BNC942746-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF594 conjugate, Concentration: 0.1mg/mL |
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
BNC802746-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF680 conjugate, Concentration: 0.1mg/mL |
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
BNC802746-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF680 conjugate, Concentration: 0.1mg/mL |
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
BNC702746-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF770 conjugate, Concentration: 0.1mg/mL |
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
BNC702746-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF770 conjugate, Concentration: 0.1mg/mL |
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
BNC882746-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF488A conjugate, Concentration: 0.1mg/mL |
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
BNC882746-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF488A conjugate, Concentration: 0.1mg/mL |
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
BNC812746-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF680R conjugate, Concentration: 0.1mg/mL |
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
BNC812746-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF680R conjugate, Concentration: 0.1mg/mL |
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
BNC402746-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF640R conjugate, Concentration: 0.1mg/mL |
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
BNC402746-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF640R conjugate, Concentration: 0.1mg/mL |
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
BNC052746-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF405M conjugate, Concentration: 0.1mg/mL |